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50a Sunday, February 3, 2013destabilizing conditions, WT myoc-OLF has a distinct non-native structure ca-
pable of forming amyloid fibrils. In the case of disease-causing myocilin vari-
ants, this non-native structure is accessible under physiological conditions,
leading to accelerated fibril growth. Building on the hypothesis that partial un-
folding of myoc-OLF is necessary for fibril growth, this study also investigates
the structural and biophysical effects of adding stabilizing agents, such as os-
molytes and Ca2þ, to the myoc-OLF domain as a strategy to prevent myoc-
OLF amyloid aggregation. The results of this study suggest a novel protein-
based hypothesis for glaucoma pathogenesis and the need for further testing
in a clinical setting.
255-Pos Board B24
Understanding the Mechanism of Somatostatin-14 Amyloid Formation
In Vitro
Anoop A, Srivastav Ranganathan, Bhagwan Das Dhaked, Reeba Susan Jacob,
Ashutosh Kumar, Ranjith Padinhateeri, Samir Kumar Maji.
IIT Bombay, Mumbai, India.
Somatostatin-14 (SST-14) is a small cyclic peptide hormone secreted by
hypothalamus, one of the well-known functions of which in the body is growth
hormone inhibition. SST-14 has previously been reported to spontaneously
self-assemble in water containing 150 mM NaCl into amyloid-like nanofibrils.
Recently, it was shown that SST-14 forms amyloid in presence of glycosami-
noglycan heparin at secretory granule relevant conditions. However, the path-
way of its amyloid formation in not understood yet. In the present work, we
studied the mechanism of SST-14 amyloid formation in vitro as well as in
silico, in the presence and absence of heparin. Our in vitro data suggests that
SST-14 in presence of heparin, transforms from its monomeric ‘random coil’
conformation to a secondary structure representing amyloid, via a ‘helix-rich
intermediate. It was observed in this study that SST-14 adopts a ‘nucleation-de-
pendent polymerization’ mechanism of amyloid formation. We also studied the
disulphide bond reduced ‘non-cyclic’ SST-14 (ncSST) form for amyloid forma-
tion, and observed that ncSST formed amyloid fibrils instantaneously in pres-
ence of heparin compared to the cyclic form. Furthermore, the ncSST fibrils
were observed to possess higher conformational and thermal stability relative
to the cyclic SST-14 fibrils.
Using all-atom molecular dynamics simulations, we studied molecular interac-
tions among SST-14 peptides in the presence and absence of heparin. Our in
silico results suggest that heparin induces aggregation of SST-14 by increasing
local concentration of the peptides and promotes interpeptide contacts and sec-
ondary structure transformation in the peptides. Overall, this study offers the
mechanism of somatostatin-14 oligomerization and amyloid formation, which
has substantial value in understanding its storage within secretory granules.
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It is widely recognized that peptide assembly into fibrils (or amyloids) sensi-
tively responds to conditions set by myriad cellular solutes. These cosolutes in-
clude two important classes: macromolecular crowders and compatible
osmolytes. In effort to resolve the effect by which these cosolutes control pep-
tide self-assembly, we have recently found that addition of macromolecular
PEG only slightly affects fibril formation of a model peptide in vitro. Polyol
osmolytes, in contrast, lengthen the lag time for aggregation, and lead to larger
fibril mass at equilibrium. Model calculations suggest that all cosolutes simi-
larly lengthen the time required for nucleation, possibly due to their excluded
volume effect. However, PEGs may in addition promote fibril fragmentation,
leading to lag times that are overall almost unvaried. Moreover, polyols effec-
tively slow the monomer-fibril detachment rates, thereby favoring additional
fibril formation. Preliminary results from coarse-grained molecular dynamics
allow us to follow the first steps of protein assembly and nucleation. Input
from experimental solvation thermodynamics of a model peptide are used to
calibrate our simulations, and to test the effect of cosolutes on peptide assembly
into proto-fibrils. Our analysis provides first hints that cosolutes act not only by
changing association or dissociation rates of peptide self assembly, but poten-
tially also by directing the formation of fibrils of varied morphologies with dif-
ferent mechanical properties. Importantly, hydration interactions are suggested
as an integral component that directs this process. Although additional exper-
iments are needed to unambiguously resolve the action of excluded cosolutes
on amyloid formation, it is becoming clear that these compounds are important
to consider in the search for ways to modulate fibril formation.
1. S. Sukenik, R. Politi, L. Ziserman, D. Danino, A. Friedler, and D. Harries,
PloS one, 2011, 6, e15608.
2. S. Sukenik and D. Harries, Prion, 2012, 6, 26-31.257-Pos Board B26
A Class of Ultrasmall Aliphatic PeptidesMimics Natural Fibrous Scaffolds
by Self-Assembly
Charlotte A. Hauser.
Institute of Bioengineering and Nanotechnology, Singapore, Singapore.
A class of ultrasmall tri to hepta peptides self-assemble into hydrogels, due to
their characteristic sequence motif - an aliphatic amino acid tail of decreasing
hydrophobicity capped by a polar head. These peptides organize themselves to
supramolecular scaffolds of long helical fibers that extend to the mm-range.
During self-assembly, these peptides form amyloid aggregates via unexpected
a-helical intermediates, with the trimer as the shortest ever reported sequence
with a-helical propensities. Circular dichroism and X-ray diffraction confirmed
conformational changes terminating in thermo-stable b-type structures. Molec-
ular dynamics simulations of peptide behavior in water revealed monomer
antiparallel pairing and stably condensed coiled fibers. The assembled macro-
structures are biocompatible and non-toxic. Their high mechanical strength
can be tuned by adjusting salt and pH, paving the way for applications from in-
jectable therapies to repair and replacement of damaged tissues. In particular,
their biocompatibility towards a variety of human and othermammalian primary
cells, qualifies them for future applications
in tissue engineering andmedical regenera-
tive therapy. The ultrasmall size and the dy-
namic facile assembly process make this
peptide class an excellent model system
for studying the mechanism of amyloido-
genesis, its evolution and pathogenicity.258-Pos Board B27
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Many soluble proteins self-assemble into fibrillar, b-sheet rich, stable aggre-
gates that are each associated with a particular disease. It is thought that peptide
segments within these proteins form the core amyloidogenic region that drives
fibrillization of the protein, and it has been shown that these segments, alone,
form fibrillar structures. Here, we seek to determine the nature of fiber nucle-
ation of these peptides. Amyloid fibers can be nucleated via a fiber-
dependent pathway in which additional protein adds onto the ends and extends
existing fibers. However, it is hypothesized that the walls of existing fibers can
also nucleate amyloid fibers in a peptide-specific manner using the solvent-
exposed side chains as a template. Conditions necessary for aggregation have
been investigated for a set of amyloidogenic peptides. We have found that ag-
gregation depends on peptide and salt concentration and occurs on the time-
scale of hours. We have also employed a novel approach for presenting an
amyloid fiber wall without presenting fiber ends. These studies illustrate the
conditions and geometry important for novel nucleation mechanisms of fiber
formation.
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Surface layer (S-layer) proteins form a highly ordered crystalline, yet porous,
layer on the outermost cell surface of most species of bacteria and archaea.
S-layers not only provide the cell a layer for protection, they are postulated
to mediate several functions such as cell adhesion, drug resistance and provid-
ing a scaffold for mineralization. Thus, S-layers provide a robust in vitro model
system to test our understanding of the dynamics of self-assembly pathways, as
well as a biological scaffold for hierarchical assembly of nano-materials. The
SbpA protein from Lysinibacillus sphaericus is a well characterized S-layer
protein that forms Ca2þ dependent, 2D crystals in solution with square symme-
try. Here we use ensemble techniques to study the self-assembly process in so-
lution. We use light scattering to follow assembly kinetics and determine
a phase a diagram for crystallization; moreover we use electron microscopy
and SAXS to confirm that SbpA forms large crystalline sheets in solution, de-
tectable by our assay. Surprisingly, we find that while SbpA requires a minimal
amount of Ca2þ to crystallize, excess divalent ions in solution inhibit interac-
tion between subunits and thus self-assembly. In addition, we find that the crys-
tallization of SbpA does not require the formation of a nucleus, and that all the
steps for self-assembly are energetically favorable. We propose a model in
